Vector co-founder Brendan Frey on using AI to transform drug discovery, development and innovation

April 3, 2019

Related:

Keith Strier and Tony Gaffney speak on stage at the Remarkable 2024 conference.

Remarkable 2024 spotlights Canada’s flourishing ecosystem

Merck and Vector logos
News
Partnership

Merck Canada announces collaboration with Vector Institute

Insights

12 AI Trends to watch for in 2024